SlidesetViral Hepatitis and Liver DiseaseImdusiran Combinations Achieving HBsAg Loss_Karen Sims.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseEfficacy of Cams across Patient Cohorts - HBeAg+ vs. HBeAg-_Tse-I Lin.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseImmunological Editing to Drive HBsAg Production from Integrated HBV DNA vs. Infected HepatocTyes_Adam Gehring.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseNext Generation Tests for HBcAg and HBcrAg - Increased Sensitivity and Utility_Mark Sulkowski.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseInsights from Intrahepatic Analysis in Clinical Trials for Chronic Hepatitis B_Jordan Feld.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseProspects for Gene Editing in CHB Cure Regimens_Fabien Zoulim.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseStrategies and Potential for SiRNA + ASO Combinations_Dickens Theodore.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseRNA Interference Combined with Immune Modulation - Are There Clinical Features That Identify HBsAg Loss_Ed Gane.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseSustainability of HBsAg Loss after Treatment - When Do We Call It Functional Cure_Harry Janssen.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseTCR Gene Therapy in Clinical Application for Chronic Hepatitis B and HBV-Related HCC_Karin Wisskirchen.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseTherapeutic Vaccine with Novel Checkpoint Inhibition_Sue Currie.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseIntrahepatic Landscape in the Delta Infected, Bulevirtide Treated Liver_Maura DandriView Slideset
SlidesetViral Hepatitis and Liver DiseaseAdditive Benefit of Mab in SiRNA + IFN-α Combinations_Carey HwangView Slideset
